Oral Wegovy dose schedule — the complete 68-week escalation guide

# Oral Wegovy dose schedule — the complete 68-week escalation guide

If you have been prescribed oral Wegovy (semaglutide tablets), you may have noticed the dose starts surprisingly low. At 1.5mg, the first four weeks feel almost like a warm-up. That is intentional. The dose escalation programme built into oral Wegovy is one of the most carefully designed aspects of the treatment — and understanding why it works the way it does makes the whole 68-week journey considerably easier to navigate.

This guide walks through every stage of the oral Wegovy dose schedule, explains what is happening in your body at each step, and covers what to do if the going gets rough.

> **Important:** This is a prescription-only medicine. Your individual dose schedule should always be agreed with and supervised by your prescribing clinician. The information here is for general guidance only.

—

## Why dose escalation exists — it is about tolerability, not speed

Here is something that surprises a lot of people: ramping up slowly does not make oral Wegovy work faster or better in the end. The escalation schedule exists entirely to help your body adjust to semaglutide gradually.

Semaglutide works by activating GLP-1 receptors throughout the body, including in the gut. When you first start, your digestive system is not used to this signal. Common side effects — nausea, mild stomach discomfort, changes in bowel habits — tend to be most pronounced early on and most severe if you jump straight to a high dose.

By starting low and moving up in steps, the escalation period gives your body time to adapt. Most people find that what felt uncomfortable at week one is entirely manageable by week eight, precisely because they have moved through the doses gradually. Think of it less like a countdown to the “real” dose and more like acclimatising before a long trek.

—

## The complete oral Wegovy dose table

| Weeks | Dose | Notes |
|——-|——|——-|
| 1–4 | 1.5 mg once daily | Starting dose. Tolerance-building phase. |
| 5–8 | 4 mg once daily | First step up. Nausea risk increases temporarily. |
| 9–12 | 8 mg once daily | Mid-escalation. Appetite suppression often becomes more noticeable. |
| 13–16 | 16 mg once daily | Approaching therapeutic range. |
| 17 onwards | 25 mg once daily | Maintenance dose. This is where most of the clinical benefit was observed in trials. |

Each tablet is taken once daily, at least 30 minutes before your first food, drink, or other oral medicines of the day. It is swallowed whole with no more than 120ml of plain water. These are not optional instructions — the absorption of oral semaglutide is highly sensitive to timing and what you take it with.

—

## What to expect at each stage

### Weeks 1–4: 1.5mg

Most people tolerate this starting dose well. You may notice a mild reduction in appetite, but significant weight change at this stage is not the goal. This phase is purely about letting your gut adapt to semaglutide. Some people experience a little nausea after taking the tablet, particularly in the first few days — this usually settles within the first week or two.

### Weeks 5–8: 4mg

The first dose increase is where some people notice a temporary uptick in nausea. This is normal and typically resolves within a week or so of the new dose. Eating smaller, lower-fat meals can help. Avoid lying down immediately after taking the tablet. If nausea is making daily life difficult, speak to your prescriber — do not push through in silence.

### Weeks 9–12: 8mg

By this point, many people report that their appetite has meaningfully changed. Food feels less central. Portion sizes may reduce naturally. This is the GLP-1 mechanism working as intended — semaglutide slows gastric emptying and signals to the brain that you are full. Side effects, if they appeared earlier, often begin to ease at this stage as your body has had time to adapt.

### Weeks 13–16: 16mg

You are now in the upper range of the escalation. Weight loss, if it has not been visible before, often becomes more apparent here. Energy levels can fluctuate as your body composition shifts. Staying well hydrated and maintaining protein intake are both worth prioritising. Your prescriber may want a check-in around this point to review your progress.

### Week 17 onwards: 25mg maintenance

This is the target dose used in the OASIS 2 clinical trial, where participants achieved an average of 15.1% body weight reduction over 68 weeks. Reaching 25mg is the point at which most of the published clinical data applies. Many people find this dose well tolerated by now because of the gradual build-up that preceded it.

—

## What happens if you cannot tolerate a dose increase

Not everyone moves through the schedule at the same pace, and that is fine. If a dose increase brings side effects that feel unmanageable — persistent nausea, vomiting, or significant digestive discomfort — your prescriber can slow the escalation.

In practice, this might mean staying at a lower dose for an additional four weeks before attempting the next step up. There is no clinical requirement to reach 25mg on the standard schedule. The goal is to reach the maintenance dose in a way that is sustainable for you.

What you should not do is stop and restart without guidance. Stopping semaglutide and then restarting at a higher dose can cause a significant return of side effects. If you are struggling, the right move is always a conversation with your prescribing clinician.

—

## The 25mg maintenance dose — does everyone reach it?

In clinical trials, most participants did reach the 25mg maintenance dose — but real-world experience is more varied. Some people tolerate every step up without difficulty. Others need extra time at one or more stages. A smaller number find that a lower dose already delivers meaningful benefit and agree with their prescriber to maintain there.

What matters most is not hitting 25mg on a specific date, but reaching the dose that is both effective and tolerable for you over the long term. Weight management with oral semaglutide is a sustained commitment, not a sprint.

—

## What happens if you miss doses

Missing occasional doses happens. The guidance is broadly: if you miss a dose and remember later the same day, take it as soon as you remember (still following the 30-minute-before-food rule). If you have already eaten, skip that day’s dose entirely and resume the next morning.

Where missed doses become more significant is during the escalation phase. If you miss several doses in a row — due to illness, supply gaps, or other reasons — your tolerance may reset. Restarting at a higher dose after a break can cause side effects to return. Your prescriber can advise on whether to return to a lower dose temporarily and re-escalate.

This is one reason why tracking availability and planning ahead matters. CompareWegovyPrices.co.uk lets you track verified provider prices and stock status so you are less likely to be caught short.

—

## After 68 weeks — what then?

The 68-week figure comes from the duration of the OASIS 2 trial. It is not a cliff edge. Many people who respond well continue treatment beyond this point, and ongoing prescribing beyond 68 weeks is supported by clinical guidance where appropriate.

What is clearly established by the trial data — and by experience with injectable semaglutide — is that stopping treatment tends to lead to weight regain over time. Semaglutide does not cure the underlying biology that drives weight gain; it manages it while you are taking it. For that reason, decisions about stopping, continuing, or transitioning to another treatment should always be made with your prescriber, not unilaterally.

The 68-week mark is a milestone worth discussing with your clinician — ideally before you reach it, so there is a clear plan in place.

—

## Frequently asked questions

### Can I skip ahead in the oral Wegovy dose schedule if I feel fine?

No. The escalation schedule should be followed as prescribed. Even if you are tolerating a dose well, moving ahead too quickly increases the risk of side effects at higher doses. Always follow the schedule agreed with your prescriber.

### What if I feel sick every time I increase my dose?

Temporary nausea with each dose increase is common and usually settles within a week. If it does not, or if it is severe, contact your prescriber. They can consider extending the time at the current dose before moving up.

### Does the dose schedule change if I am not losing weight?

The dose schedule is designed to reach the maintenance dose regardless of early weight loss. Weight loss often becomes more pronounced once you reach 16mg or 25mg. If you are at the maintenance dose and not seeing results, discuss this with your prescriber rather than adjusting doses yourself.

### Is the 1.5mg dose doing anything useful?

Yes — it is introducing semaglutide to your system in a way your gut can adapt to. It is not a placebo phase. Some people do notice early appetite changes even at 1.5mg. But the primary purpose at this stage is tolerability, not maximum efficacy.

### Can I take oral Wegovy with my morning coffee?

No. The tablet should be taken with plain water only — no more than 120ml — and nothing else should be consumed for at least 30 minutes afterwards. Coffee, tea, food, juice, and other medicines all reduce absorption significantly.

### How does the oral dose schedule compare to the injectable version?

Injectable Wegovy (subcutaneous semaglutide) has its own escalation: starting at 0.25mg weekly and reaching 2.4mg weekly over approximately 16–20 weeks. The oral version takes longer to escalate because the doses are not directly comparable — oral semaglutide is absorbed much less efficiently than the injection, so higher doses are needed to achieve similar blood levels.

—

*This article is for informational purposes only and does not constitute medical advice. Oral Wegovy (semaglutide) is a prescription-only medicine available in the UK. Always consult a registered UK healthcare professional before starting any weight management treatment. CompareWegovyPrices.co.uk is not affiliated with Novo Nordisk.*